Preparation of griseofulvin nanoparticle suspension by high-pressure homogenization and preservation of the suspension with saccharides and sugar alcohols

Drug Development and Industrial Pharmacy

Volumn 35, Issue 8, 2009, Pages 1022-1028

  Kamiya, Seitaro ^a,b   Kurita, Takurou ^b,c   Miyagishima, Atsuo ^b   Arakawa, Masayuki ^a  

^a NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

^c TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Freeze drying; High pressure homogenization; Nanoparticle suspension; Particle size; Rehydration; Saccharides; Sugar alcohols

Indexed keywords

ERYTHRITOL; GRISEOFULVIN; LACTOSE; NANOPARTICLE; PHOSPHATIDYLCHOLINE; SUCROSE; TREHALOSE; XYLITOL;

ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; FREEZE DRYING; PARTICLE SIZE; PRESSURE;

ANTIFUNGAL AGENTS; BIOLOGICAL AVAILABILITY; DRUG STABILITY; ERYTHRITOL; EXCIPIENTS; FREEZE DRYING; GRISEOFULVIN; LACTOSE; NANOPARTICLES; PARTICLE SIZE; SOLUBILITY; SUCROSE; SUSPENSIONS; TREHALOSE; XYLITOL;

EID: 70350697800     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802698786     Document Type: Article

References (65)

1. Kim CK, Cho YJ, Gao ZG. (2001). Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery. J Control Release, (1-2):149-155
2. Kawakami K, Miyoshi K, Ida Y. (2004). Solubilization behavior of poorly soluble drugs with combined use of Gelucire 44/14 and cosolvent. J Pharm Sci, 93(6):1471-1479
3. Sheng JJ, Kasim NA, Chandrasekharan R, Amidon GL. (2006). Solubilization and dissolution of insoluble weak acid, ketoprofen: Effects of pH combined with surfactant. Eur J Pharm Sci, 29(3-4):306-314
4. Jain P, Yalkowsky SH. (2007). Solubilization of poorly soluble compounds using 2-pyrrolidone. Int J Pharm, 342(1-2):1-5.
5. Cui SX, Nie SF, Li L, Wang CG, Pan WS, Sun JP. (2008). Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Dev Ind Pharm, 28:1-9.
6. Borhade VB, Nair HA, Hegde DD. (2008). Development and characterization of self-microemulsifying drug delivery system of tacrolimus for intravenous administration. Drug Dev Ind Pharm, 31:1-12.
7. Dixit RP, Nagarsenker MS. (2008). Formulation and in vivo evaluation of self-nanoemulsifying granules for oral delivery of a combination of ezetimibe and simvastatin. Drug Dev Ind Pharm, 34(12):1285-1296
8. Bashiri-Shahroodi A, Nassab PR, Szabó-Révész P, Rajkó R. (2008). Preparation of a solid dispersion by a dropping method to improve the rate of dissolution of meloxicam. Drug Dev Ind Pharm, 34(7):781-788
9. Donato EM, Martins LA, Fröehlich PE, Bergold AM. (2008). Development and validation of dissolution test for lopinavir, a poorly water-soluble drug, in soft gel capsules, based on in vivo data. J Pharm Biomed Anal, 47(3):547-552
10. Yamada T, Saito N, Imai T, Otagiri M. (1999). Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug. Chem Pharm Bull, 47(9):1311-1313
11. Shu T, Suzuki H, Hironaka K, Ito K. (2002). Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone. Chem Pharm Bull, 50(2):193-198
12. Friedrich H, Nada A, Bodmeier R. (2005). Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers. Drug Dev Ind Pharm, 31(8):719-728
13. Vijaya Kumar SG, Mishra DN. (2006). Preparation, characterization and in vitro dissolution studies of solid systems of valdecoxib with chitosan. Chem Pharm Bull, 54(8):1102-1106
14. Garg A, Singh S, Rao VU, Bindu K, Balasubramaniam J. (2008). Solid state interaction of raloxifene HCl with different hydrophilic carriers during co-grinding and its effect on dissolution rate. Drug Dev Ind Pharm, 1:1-16.
15. Fujii M, Bouno M, Fujita S, Yoshida M, Watanabe Y, Matsumoto M. (2000). Preparation of griseofulvin for topical application using N-methyl-2- pyrrolidone. Bio Pharm Bull, 23(11):1341-1345
16. Atkinson RM, Bedford C, Child KJ, Tomich EG. (1962). Effect of particle size on blood griseofulvin-levels in man. Nature, 193:588-589
17. Chattopadhyay P, Gupta RB. (2001). Production of griseofulvin nanoparticles using supercritical CO2 antisolvent with enhanced mass transfer. Int J Pharm, 228(1-2):19-31. (Pubitemid 32905362)
18. Eyjolfsson R. (1999). Nitrofurantoin: Particle size and dissolution. Drug Dev Ind Pharm, 25(1):105-106
19. Rasenack N, Hartenhauer H, Müller BW. (2003). Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int J Pharm, 254(2):137-145
20. Perrut M, Jung J, Leboeuf F. (2005). Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I: Micronization of neat particles. Int J Pharm, 288(1):3-10. (Pubitemid 39656449)
21. Hecq J, Deleers M, Fanara D, Vranckx H, Amighi K. (2005). Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm, 299(1-2):167-177
22. Peters K, Muller RH, Craig DQ. (1999). An investigation into the distribution of lecithins in nanosuspension systems using low frequency dielectric spectroscopy. Int J Pharm, 184(1):53-61.
23. Jacobs C, Kayser Q, Müller RH. (2000). Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int J Pharm, 196(2):161-164
24. Kraml M, Dubuc J, Gaudry R. (1962). Gastrointestinal absorption of griseofulvin. II. Influence of particle size in man. Antibiot Chemother, 12:239-242
25. Jani P, Halbert GW, Langridge J, Florence AT. (1990). Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. J Pharm Pharmacol, 42:821-826
26. Kwok KY, Adam RC, Hester KC, Park Y, Thomas S, Rice KG. (2000). Strategies for maintaining the particle size of peptide DNA condensates following freeze-drying. Int J Pharm, 203:81-88
27. Konan YN, Gurny R, Allemann E. (2002). Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int J Pharm, 233:239-252
28. Rasenack N, Müller BW. (2002). Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs. Pharm Res, 19(12):1894-1900
29. Shekunov BY, Chattopadhyay P, Seitzinger J, Huff R. (2006). Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions. Pharm Res, 23(1):196-204.
30. Chattopadhyay P, Huff R, Shekunov BY. (2006). Drug encapsulation using supercritical fluid extraction of emulsions. J Pharm Sci, 95(3):667-679
31. Möschwitzer J, Müller RH. (2006). New method for the effective production of ultrafine drug nanocrystals. J Nanosci Nanotechnol, 6(9-10):3145-3153
32. Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ. (1999). Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release, 59(3):299-307.
33. Rampon V, Riaublanc A, Anton M, Genot C, McClements DJ. (2003). Evidence that homogenization of BSA-stabilized hexadecane- in-water emulsions induces structure modification of the nonadsorbed protein. J Agric Food Chem, 51(20):5900-5905
34. Xu XM, Li Q, Zhu Y, Shen S, Shen Z, Yu JN. (2005). Study on the preparation and bio-distribution of silybin lipid nanospheres. Zhongguo Zhong Yao Za Zhi, 30(24):1912-1914
35. Hernández A, Harte FM. (2008). Manufacture of acid gels from skim milk using high-pressure homogenization. J Dairy Sci, 91(10):3761-3767
36. Nilsson L, Leeman M, Wahlund KG, Bergenståhl B. (2006). Mechanical degradation and changes in conformation of hydrophobically modified starch. Biomacromolecules, 7(9): 2671-2679
37. Nozawa Y, Kamiya S, Sadzuka Y, Atsuo M, Sonobe T. (2004). Adding effect of saccharide to microsuspension particle size of griseofulvin-lipid mixtures subjected freeze-drying and rehydration. Kagaku Kogaku Ronbunshu, 30:43-46
38. Adkins SS, Hobbs HR, Benaissi K, Johnston KP, Poliakoff M, Thomas NR. (2008). Stable colloidal dispersions of a lipaseperfluoropolyether complex in liquid and supercritical carbon dioxide. J Phys Chem B, 112(15):4760-4769
39. Hayes ME, Drummond DC, Hong K, Park JW, Marks JD, Kirpotin DB. (2006). Assembly of nucleic acid-lipid nanoparticles from aqueous-organic monophases. Biochim Biophys Acta, 1758(4):429-442
40. Morale D, Capasso V, Oelschläger K. (2005). An interacting particle system modelling aggregation behavior: From individuals to populations. J Math Biol, 50(1):49-66.
41. Floyd R, Sharp DG. (1978). Viral aggregation: Quantitation and kinetics of the aggregation of poliovirus and reovirus. Appl Environ Microbiol, 35(6):1079-1083 (Pubitemid 8362591)
42. Lomakin A, Teplow DB, Benedek GB. (2005). Quasielastic light scattering for protein assembly studies. Methods Mol Biol, 299:153-174
43. Hayes ME, Drummond DC, Hong K, Park JW, Marks JD, Kirpotin DB. (2006). Assembly of nucleic acid-lipid nanoparticles from aqueous-organic monophases. Biochim Biophys Acta, 1758(4):429-442
44. Wildman RD, Huntley JM, Hansen JP, Parker DJ, Allen DA. (2000). Single-particle motion in three-dimensional vibrofluidized granular beds. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics, 62(3 Pt B):3826-3835
45. Ellero M, Español P, Flekkøy EG. (2003). Thermodynamically consistent fluid particle model for viscoelastic flows. Phys Rev E Stat Nonlin Soft Matter Phys, 68(4 Pt 1):041504.
46. Witkoskie JB, Wu J, Cao J. (2004). Basis set study of classical rotor lattice dynamics. J Chem Phys, 120(12):5695-5708
47. Mauger A. (2005). Brownian motion in an aging medium. Phys Rev E Stat Nonlin Soft Matter Phys, 71(1 Part 1):011109.
48. Coffey WT, Kalmykov YP, Titov SV, Cleary L. (2008). Smoluchowski equation approach for quantum Brownian motion in a tilted periodic potential. Phys Rev E Stat Nonlin Soft Matter Phys, 78(3 Pt 1):031114.
49. Zhang H, Wang D, Butler R, Campbell NL, Long J, Tan B, et al. (2008). Formation and enhanced biocidal activity of waterdispersable organic nanoparticles. Nat Nanotechnol, 3(8):506-511
50. Lim SB, Rubinstein I, Onyüksel H. (2008). Freeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles. Int J Pharm, 356(1-2):345-350
51. Ueno K, Inaba A, Kondoh M, Watanabe M. (2008). Colloidal stability of bare and polymer-grafted silica nanoparticles in ionic liquids. Langmuir, 24(10):5253-5259
52. Lee J, Kim J, Park E, Jo S, Song R. (2008). PEG-ylated cationic CdSe/ZnS QDs as an efficient intracellular labeling agent. Phys Chem Chem Phys, 10(13):1739-1742
53. Gao L, Zhang D, Chen M, Zheng T, Wang S. (2007). Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement. Drug Dev Ind Pharm, 33(12):1332-1339
54. Anhorn MG, Mahler HC, Langer K. (2008). Freeze drying of human serum albumin (HSA) nanoparticles with different excipients. Int J Pharm, 363(1-2):162-169
55. Zhao XL, Chen HB, Chen YJ, Yang XL. (2007). [Freeze-drying of oleanolic acid-loaded nanosuspensions]. Zhongguo Zhong Yao Za Zhi, 32(18):1874-1876
56. Saez A, Guzmán M, Molpeceres J, Aberturas MR. (2000). Freeze-drying of polycaprolactone and poly (D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur J Pharm Biopharm, 50(3):379-387
57. Teeranachaideekul V, Junyaprasert VB, Souto EB, Müller RH. (2008). Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. Int J Pharm, 354(1-2):227-234
58. Oh KS, Han SK, Lee HS, Koo HM, Kim RS, Lee KE, et al. (2006). Core/Shell nanoparticles with lecithin lipid cores for protein delivery. Biomacromolecules, 7(8):2362-2367
59. Shaik MS, Ikediobi O, Turnage VD, McSween J, Kanikkannan N, Singh M. (2001). Long-circulating monensin nanoparticles for the potentiation of immunotoxin and anticancer drugs. J Pharm Pharmacol, 53(5):617-627
60. Qiu L, Jing N, Jin Y. (2008). Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method. Int J Pharm, 361(1-2):56-63.
61. Lalanne M, Andrieux K, Paci A, Besnard M, Ré M, Bourgaux C, et al. (2007). Liposomal formulation of a glycerolipidic prodrug for lymphatic delivery of didanosine via oral route. Int J Pharm, 344(1-2):62-70.
62. Koo OM, Rubinstein I, Onyuksel H. (2005). Camptothecin in sterically stabilized phospholipid micelles: A novel nanomedicine. Nanomedicine, 1(1):77-84.
63. Crowe JH, Crowe LM. (1992). Preservation of liposomes by freeze-drying. In: Gregoriadis G, ed. Liposome technology, vol.1, Liposome preparation and related techniques, 2nd ed. Boca Raton: CRC Press, 229-252
64. Cui Z, Hsu CH, Mumper RJ. (2003). Physical characterization and macrophage cell uptake of mannan-coated nanoparticles. Drug Dev Ind Pharm, 29(6):689-700.
65. Li B, Li S, Tan Y, Stolz DB, Watkins SC, Block LH, et al. (2000). Lyophilization of cationic lipid-protamine-DNA (LPD) complexes. J Pharm Sci, 89(3):355-364